Current therapy for condyloma acuminata of the patients attending female STD Unit, Siriraj Hospital.
OBJECTIVE
To describe the treatment pattern of condyloma acuminata in female.


METHODS
The 5-year medical records of 449 women treated for genital condyloma acuminata at the Gynecologic Infectious Diseases and Female Sexually Transmitted Disease (GID-FSTD) unit were reviewed. Data included the distribution of age, client by category, anatomical site and size, serologically coexisting sexually transmitted infection (STI), and treatment modalities.


RESULTS
About half, 50.1%, of treatment was the application of topical trichloroacetic acid; followed by podophylline in the proportion of 35.5%. While the electric cauterization and imiquimod applications were uncommon therapy. Two-fifth ofthe subjects, 40.7%, was completely cured, and the remaining cases required additional management.


CONCLUSIONS
The present setting, the wide range of treatment available is reflection of the fact that there is no ideal management.
Roongpisuthipong
Anuvat
A
Gynecologic Infectious Diseases and Female Sexually Transmitted Disease Unit, Department of Obstetrics and Gynecology, Siriraj Hospital, Bangkok, Thailand. siarp@mahidol.ac.th
Chalermchockcharoenkit
Amphan
A
Thamkhantho
Manopchai
M
Thanaboonyawat
Isarin
I
Neungton
Chanon
C
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage; D002424:Caustics / Q000008:administration & dosage; D002425:Cautery; D003218:Condylomata Acuminata / Q000628:therapy*; D005260:Female; D005831:Genital Diseases, Female / Q000628:therapy*; D006801:Humans; D000077271:Imiquimod; D009824:Ointments; D011033:Podophyllin / Q000008:administration & dosage; D012189:Retrospective Studies; D016896:Treatment Outcome; D014238:Trichloroacetic Acid / Q000008:administration & dosage; D055815:Young Adult
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D002424:Caustics; D009824:Ointments; D014238:Trichloroacetic Acid; D011033:Podophyllin; D000077271:Imiquimod